source
- Revolution Medicines sees strong demand for pancreatic cancer drug daraxonrasib under compassionate useRevolution Medicines reports that more than 2,000 patients have received its pancreatic cancer candidate daraxonrasib through a compassionate use program. The company says the drug has been distri…
- Bristol Myers Squibb expands Nvidia partnership to build most powerful AI supercomputer for drug discoveryBristol Myers Squibb announced an expanded partnership with Nvidia that will give it the most powerful and energy-efficient Nvidia infrastructure owned by a life-science company. Nvidia says the p…